Progressive hyperpigmentation and lentigines due to KIT variants improving with imatinib
British Journal of Dermatology · 2024
DOI: 10.1093/bjd/ljae109 ↗Kurz gefasst
Leserbrief in der Zeitschrift British Journal of Dermatology, 2024. Verfasst von Lina Liang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Hospital, Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Imatinib Mesylate, Hyperpigmentation, Lentigo, Proto-Oncogene Proteins c-kit. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 2 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Dermatology Hospital, Southern Medical University, Guangzhou, China.
ORCID-Profile: Huijun Wang, Zhimiao Lin
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Liang, L., Peng, S., Huang, S., Wang, H., & Lin, Z. (2024). Progressive hyperpigmentation and lentigines due to KIT variants improving with imatinib. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljae109
Vancouver
Liang L, Peng S, Huang S, Wang H, Lin Z. Progressive hyperpigmentation and lentigines due to KIT variants improving with imatinib. British Journal of Dermatology. 2024. doi:10.1093/bjd/ljae109
BibTeX
@article{Liang2024,
author = {Liang, Lina and Peng, Sha and Huang, Shimiao and Wang, Huijun and Lin, Zhimiao},
title = {Progressive hyperpigmentation and lentigines due to KIT variants improving with imatinib},
journal = {British Journal of Dermatology},
year = {2024},
doi = {10.1093/bjd/ljae109}
}
EUVIMED